The Role of Blinatumomab in CD19-Positive Precursor B-Cell Acute Lymphoblastic Leukemia Philadelphia-Negative Disease: A 3-Year Update on Progression-Free Survival (SOHO 2026) - Sep 1, 2026 - Abstract #ALL-840; Location: LEVEL 3, HALL B3; "Blinatumomab is a new drug used to bridge patients to allogeneic bone marrow transplant in patients with acute lymphoblastic leukemia with unfavorable risk factors. It is used in the consolidation phase along with scheduled chemotherapy. In this small cohort, we show that blinatumomab is an effective choice in purging bone marrow at the end of induction chemotherapy."
Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Leukemia • Oncology
|